Drawing for P PERIMETER

USPTO serial 99792655

P PERIMETER

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
TWAY, TATIANA R
Law office
TMEG LAW OFFICE 105

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with P PERIMETER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua S. Jarvis, Esq.

Joshua S. Jarvis, Esq. Foley Hoag LLP155 Seaport BoulevardSeaport WestBoston, MA 02210-2600

Goods and services

ClassDescriptionStatusFirst use
009Downloadable electronic publications in the nature of reports, white papers, and articles in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biodefenseACTIVE—
041Providing online non-downloadable publications in the nature of reports, white papers, and articles in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biodefenseACTIVE—
042Providing online non-downloadable software for viewing reports and delivering, accessing, sharing, analyzing, and visualizing data in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biodefense; scientific and technological services, namely, data collection, analysis, and reporting in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biodefense; providing scientific and technological information in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biodefense; Monitoring and testing of water, air, soil, surfaces, and human and animal reservoirs for detection of contaminants, namely, viruses, pathogens, and pharmaceutical and drug contaminants; detection of contaminants, namely, viruses, pathogens, and pharmaceutical and drug contaminants in water, air, soil, surfaces, and human and animal reservoirs; scientific and technological services, namely, bio-sample testing services for others being scientific research services in the fields of biosecurity, biosurveillance, bioinformatics, biodefense, scientific research, and scientific diagnostics; scientific and technological services, namely, biosecurity surveillance in the nature of environmental inspection services and inspection of goods for biosecurity purposes, in particular, inspection of food, water, air, and environmental resources; Environmental testing consulting and scientific research consulting services for others in the field of design, planning, and implementation project management of biosecurity initiatives related to the monitoring, testing, and detection of viruses, pathogens, and pharmaceutical and drug contaminants in water, air, soil, surfaces, and human and animal reservoirs; scientific laboratory services; scientific and technological research and development in the fields of biosecurity, biosurveillance, bioinformatics, and biodefense; Environmental monitoring services, namely, water quality monitoring and testing for pathogen contentACTIVE—
044Medical consulting in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biodefense; providing medical information in the fields of viruses, pathogens, pharmaceutical and drug contaminants, diagnostic testing, pandemic response, biosecurity, biosurveillance, bioinformatics, and biodefense; all of the foregoing services based on information collected from bio-sample monitoring and testing of water, air, soil, surfaces, and human and animal reservoirs; Medical testing for diagnostic purposes; the foregoing not related to imaging for medical purposes; Monitoring and testing of human and animal reservoirs for viruses and pathogens for purposes of medical and veterinary diagnosis; Virus and pathogen testing services, namely, detection of viruses and pathogens in human and animal reservoirs for medical and veterinary diagnosis purposesACTIVE—
045Surveillance services, namely, surveillance of premises for viruses, pathogens, and pharmaceutical and drug contaminants for community and global safety purposes and outbreak threat preventionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 20, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2026GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Sep 9, 2026GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Sep 9, 2026EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Sep 9, 2026CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Sep 2, 2026DOCKASSIGNED TO EXAMINER—
Aug 31, 2026MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Aug 31, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 28, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 28, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance